RNAi Screening Libraries
RNAi Screening Libraries
Invitrogen™ Silencer™ Select Human Druggable Genome siRNA Extension Set V4
For the first time, you can obtain the benefits of Ambion™Silencer™ Select siRNAs in a convenient pre-plated, library format.
Invitrogen™ Silencer™ Select Human Drug Targets siRNA Library (96 well)
The Silencer Select Human Drug Targets siRNA Library contains 23,778 Invitrogen™ Silencer Select highly potent and chemically-modified siRNAs targeting 7,926 genes for performing RNAi screens against known human drug target genes.
Invitrogen™ Silencer™ Human druggable Genome siRNA Library (96 well)
The Silencer™ Human Druggable Genome siRNA Library targets genes in the known druggable genome for performing RNAi functional screens for potential therapeutic targets.
Invitrogen™ LentiArray™ Human Ion Channel CRISPR Library
The Invitrogen™ LentiArray™ Human Ion Channel Library targets 328 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 1,312 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
Invitrogen™ LentiArray™ Human Apoptosis CRISPR Library
The Invitrogen™ LentiArray™ Human Apoptosis Library targets 904 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 3,616 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
Invitrogen™ LentiArray™ Human DNA Damage Response CRISPR Library
The Invitrogen™ LentiArray™ Human DNA Damage Response Library targets 561 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 2,244 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
Invitrogen™ LentiArray™ Human Membrane Trafficking CRISPR Library
The award-winning Invitrogen™ LentiArray™ Human Membrane Trafficking Library targets 141 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 564 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
Invitrogen™ LentiArray™ Human Transcription Factor CRISPR Library
The Invitrogen™ LentiArray™ Human Transcription Factor Library targets 1,817 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 7,268 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
LentiArray™ LentiArray™ Human Epigenetics Library, Glycerol Stock
Targets 396 genes with up to 4 gRNA per gene target for a total of 1,548 gRNAs. Libraries are delivered as 50μL of glycerol stock per gRNA and are also available as ready to use packaged lentivirus
LentiArray™ LentiArray™ Human Drug Transporter Library, Glycerol Stock
Targets 98 genes with up to 4 gRNA per gene target for a total of 392 gRNAs. Libraries are delivered as 50μL of glycerol stock per gRNA and are also available as ready to use packaged lentivirus.
LentiArray™ LentiArray™ Human Tumor Suppressor Library, Glycerol Stock
Targets 716 genes with up to 4 gRNA per gene target for a total of 2,864 gRNAs. Libraries are delivered as 50μL of glycerol stock per gRNA and are also available as ready to use packaged lentivirus
Invitrogen™ Silencer™ Human Epigenetics siRNA Library
Epigenetic regulation of gene expression is proving to be a key regulator in the development and progression of a host of human diseases.
Invitrogen™ Silencer™ Human Cancer Genome siRNA Library
The Silencer™ Human Cancer Genome siRNA Library contains 1572 Ambion™ Silencer siRNAs targeting 524 gene targets that are commonly affected in cancers.
Invitrogen™ Silencer™ Human Drug Targets siRNA Library
The Silencer™ Human Drug Targets siRNA Library includes genes involved in apoptosis, senescence, nucleic acid binding, autophagy, DNA repair, and along with characterized nuclear receptors and other genes that are considered potential targets for therapeutics.
Invitrogen™ Silencer™ Select Human Membrane Trafficking siRNA Library
The Silencer™ Select Human Membrane Trafficking siRNA Library is designed for researchers targeting proteins known or predicted to participate in membrane trafficking or remodeling.